Bloomberg says Zuckerberg has prioritized recruiting for the new team, referred internally as a “superintelligence group.” He ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Dr. Cyrus Pasamba, Novo Nordisk's senior medical manager for Clinical, Medical, Regulatory, and Pharmacovigilance, says on June 10, 202 that 'thin outside, fat inside' or TOFI' may refer to someone ...

Shares of the electric-vehicle maker were on track to continue their rebound from the rout last week that was sparked by Elon Musk's fallout with President Trump. The stock rose about 2.5% premarket.

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...

Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

--Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a new chief executive following a share-price slump, according to the ...